Total Payments
$1,897
2024 Payments
$750.41
Companies
18
Transactions
94
Medicare Patients
408
Medicare Billing
$36,217
Payment Breakdown by Category
Food & Beverage$1,747 (92.1%)
Other$150.00 (7.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,747 | 93 | 92.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $399.03 | 21 | $0 (2024) |
| ABBVIE INC. | $380.35 | 26 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $223.78 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $168.19 | 6 | $0 (2024) |
| Eko Health, Inc. | $150.00 | 1 | $0 (2024) |
| Lilly USA, LLC | $149.29 | 9 | $0 (2024) |
| PFIZER INC. | $69.69 | 4 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $60.38 | 1 | $0 (2024) |
| Bausch Health US, LLC | $55.87 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $47.36 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $750.41 | 31 | Eko Health, Inc. ($150.00) |
| 2023 | $540.18 | 33 | ABBVIE INC. ($183.20) |
| 2022 | $416.15 | 19 | Novo Nordisk Inc ($214.82) |
| 2021 | $189.97 | 11 | Novo Nordisk Inc ($104.60) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2024 | Eko Health, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| 11/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $60.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Neurology | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PAIN | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Medtronic, Inc. | CLOSUREFAST (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: EndoVenous Therapies | ||||||
| 08/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.21 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Inflammation | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Biological | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Neurology | ||||||
| 04/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Biological | ||||||
| 03/18/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 53 | 147 | $23,835 | $8,471 |
| 2022 | 4 | 102 | 199 | $26,900 | $10,907 |
| 2021 | 7 | 144 | 229 | $24,060 | $9,524 |
| 2020 | 7 | 109 | 155 | $18,785 | $7,315 |
Total Patients
408
Total Services
730
Medicare Billing
$36,217
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 126 | $23,310 | $8,271 | 35.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 21 | $525.00 | $199.92 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 114 | $21,090 | $7,894 | 37.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 37 | $2,960 | $1,523 | 51.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 30 | 33 | $2,475 | $1,346 | 54.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 15 | $375.00 | $143.92 | 38.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 88 | $14,130 | $5,870 | 41.5% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 32 | 34 | $2,550 | $1,407 | 55.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 17 | $1,910 | $985.08 | 51.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 30 | $2,250 | $762.07 | 33.9% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 15 | 22 | $1,320 | $274.36 | 20.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $1,540 | $154.15 | 10.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 24 | $360.00 | $72.00 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 68 | $10,792 | $4,101 | 38.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 22 | 22 | $2,401 | $1,050 | 43.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,865 | $879.04 | 30.7% |
| 87426 | Coronavirus ag ia | Office | 2020 | 13 | 16 | $1,200 | $565.28 | 47.1% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 12 | 12 | $585.00 | $350.76 | 60.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 11 | 14 | $666.87 | $194.09 | 29.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $275.00 | $175.01 | 63.6% |
About Bianca Pope, FNP
Bianca Pope, FNP is a Family Medicine healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1124465588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bianca Pope, FNP has received a total of $1,897 in payments from pharmaceutical and medical device companies, with $750.41 received in 2024. These payments were reported across 94 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,747).
As a Medicare-enrolled provider, Pope has provided services to 408 Medicare beneficiaries, totaling 730 services with total Medicare billing of $36,217. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family
- Location Brunswick, GA
- Active Since 05/25/2013
- Last Updated 12/19/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124465588
Products in Payments
- VRAYLAR (Drug) $346.71
- Ozempic (Drug) $226.29
- TRINTELLIX (Drug) $223.78
- REXULTI (Drug) $206.28
- EMGALITY (Drug) $86.89
- Wegovy (Drug) $79.61
- LifeVest (Device) $60.38
- Rybelsus (Drug) $60.36
- APLENZIN (Drug) $55.87
- JARDIANCE (Drug) $55.15
- Veozah (Drug) $47.36
- NURTEC ODT (Drug) $35.87
- UBRELVY (Drug) $33.64
- MOUNJARO (Drug) $28.22
- KRYSTEXXA (Biological) $21.76
- CLOSUREFAST (Device) $18.24
- COMIRNATY (Biological) $18.21
- RYBELSUS (Drug) $17.63
- TRELEGY ELLIPTA (Drug) $16.57
- Otezla (Drug) $16.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brunswick
James Fleming, M.d, M.D
Family Medicine — Payments: $6,870
Family Medicine $6,870
Michael Macdonald, Md, MD
Family Medicine — Payments: $5,525
Family Medicine $5,525
Leonard Kinland, M.d, M.D
Family Medicine — Payments: $5,252
Family Medicine $5,252
Dr. John Blumer, M.d, M.D
Family Medicine — Payments: $4,731
Family Medicine $4,731
Mark Meacham, Md, MD
Family Medicine — Payments: $3,673
Family Medicine $3,673
Jelisa Carroll
Family Medicine — Payments: $3,544
Family Medicine $3,544